|
Market Closed -
NSE India S.E.
07:05:07 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 2,910.20 INR | -0.22% |
|
+0.51% | +69.00% |
| 09-06 | Fosun Pharma Plans HK$1 Billion Share Buyback Funded by Gland Pharma Stake Sale | MT |
| 09-06 | Fosun International Unit Sells 6% Gland Pharma Stake for INR28 Billion | MT |
| Market Cap | 480B 5.01B 4.4B 4.13B 3.78B 7.06B 7.12B 49.67B 19.25B 245B 18.82B 18.41B 794B | P/E 2027 * |
36.6x | P/E 2028 * | 30.1x |
|---|---|---|---|---|---|
| Enterprise Value | 443B 4.62B 4.06B 3.81B 3.49B 6.51B 6.56B 45.79B 17.75B 226B 17.35B 16.97B 732B | EV / Sales 2027 * |
5.91x | EV / Sales 2028 * | 5.04x |
| Free-Float |
48.26% | Yield 2027 * |
0.7% | Yield 2028 * | 0.77% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLAND | Delayed | |
Bombay S.E.
| GLAND | Delayed |
Last Transcript: Gland Pharma Limited
| 1 day | -0.22% | ||
| 1 week | +0.51% | ||
| Current month | +0.85% | ||
| 1 month | +3.22% | ||
| 3 months | +33.09% | ||
| 6 months | +78.86% | ||
| Current year | +69.00% |
| 1 week | 2,820.1 |  | 3,008 |
| 1 month | 2,776.1 | | 3,042 |
| Current year | 1,573.6 | | 3,042 |
| 1 year | 1,573.6 | | 3,042 |
| 3 years | 1,277.8 | | 3,042 |
| 5 years | 861 | | 4,072 |
| 10 years | 861 | | 4,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2019-09-29 | |
| Chief Operating Officer | - | 2026-04-05 | |
Jitendra Gangwal
CTO | Chief Tech/Sci/R&D Officer | - | 2026-02-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Srinivas Sadu
CHM | Chairman | 57 | 2024-06-09 |
| Director/Board Member | 71 | 2018-02-06 | |
Naina Lal Kidwai
BRD | Director/Board Member | 69 | 2021-05-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/26/25 | Buy | 2,800 | 0.0017% | |||
| 6/28/24 | Sell | 1,950 | 0.0012% | |||
| 6/28/24 | Sell | 1,400 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +0.51% | +44.44% | +71.88% | 5.03B | |
| -1.16% | +1.54% | +54.67% | +109.20% | 1,043B | |
| -0.25% | +0.54% | +52.18% | +67.68% | 649B | |
| +0.02% | +1.02% | +19.13% | +71.48% | 469B | |
| -0.25% | +0.19% | +36.95% | +45.54% | 355B | |
| +0.98% | +2.91% | +20.59% | +27.14% | 270B | |
| -1.91% | +2.42% | +10.41% | +11.04% | 262B | |
| -0.54% | +8.53% | +42.41% | +53.06% | 222B | |
| -1.42% | +1.76% | +31.36% | +100.83% | 189B | |
| -2.53% | -7.47% | -32.63% | -60.41% | 175B | |
| Average | -0.68% | +1.93% | +27.95% | +49.74% | 363.81B | |
| Weighted average by Cap. | -0.66% | +1.79% | +36.03% | +65.50% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 74.93B 782M 687M 645M 590M 1.1B 1.11B 7.75B 3.01B 38.2B 2.94B 2.87B 124B | 85.84B 896M 786M 739M 676M 1.26B 1.27B 8.88B 3.44B 43.76B 3.37B 3.29B 142B |
| Net income | 13.12B 137M 120M 113M 103M 193M 194M 1.36B 526M 6.69B 514M 503M 21.69B | 15.95B 166M 146M 137M 126M 235M 236M 1.65B 640M 8.13B 625M 611M 26.36B |
| Net Debt | -37.45B -391M -343M -323M -295M -551M -555M -3.87B -1.5B -19.09B -1.47B -1.44B -61.9B | -47.28B -494M -433M -407M -372M -696M -701M -4.89B -1.9B -24.11B -1.85B -1.81B -78.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | ₹2,910.20 | -0.22% | 160,041 |
| 26-09-22 | ₹2,916.60 | -0.80% | 124,161 |
| 26-09-21 | ₹2,940.20 | -0.73% | 279,128 |
| 26-09-18 | ₹2,961.90 | +1.86% | 492,452 |
| 26-09-17 | ₹2,907.80 | +2.87% | 678,985 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAND Stock
Select your edition
All financial news and data tailored to specific country editions
